Can tucatinib/tucatinib be purchased abroad?
Tucatinib/Tucatinib, an oral tyrosine kinase inhibitor that is highly selective for the HER2 kinase domain, has not yet been officially launched in China, but it is still possible for patients in urgent need to obtain it through some legal channels. Since the original drug is not sold in China, patients cannot purchase it directly in domestic hospitals and pharmacies.
However, patients still have the opportunity to obtain this drug through overseas purchases or purchasing agents. When performing such operations, patients need to pay special attention to ensuring the reliability and legality of the source of the drugs to avoid purchasing counterfeit and substandard drugs. At the same time, different versions and specifications of tucatinib will have different prices, and patients need to make reasonable choices based on their own economic status and actual needs.
As a new anti-cancer drug, tucatinib has shown significant anti-tumor activity in patients with HER2-positive metastatic breast cancer (including patients with brain metastases) in combination with trastuzumab and capecitabine in a phase 1b dose-escalation trial. Its unique mechanism of action, which targets both the internal and external domains of HER2, brings patients hope for better survival. Although most adverse events of tucatinib are mild, such as diarrhea, nausea, palmar-plantar dysesthesia syndrome, fatigue and vomiting, patients still need to pay close attention to their physical condition during use and provide timely feedback to their doctors.
Currently, tucatinib is available in two forms: original drug and generic drug in overseas markets. Although the ingredients of the drugs are basically the same, there is a big difference in price. For example, the price of the European version of the original drug may be as high as more than 70,000 yuan per box, while the price of the Bangladeshi generic drug may be more than 4,000 yuan per box. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)